Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe.
Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as ...
Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...
Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves ...
More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
Oral semaglutide: Less common type of semaglutide. Administered either as a tablet or liquid drops, typically in a daily ...
Ozempic could be behind a “concerning” return of skinny models, the editor of British Vogue magazine has said. Chioma Nnadi ...
New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...
The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...
The Impact of New Weight Loss Drugs on Dietetics By Carrie Dennett, MPH, RDN Today’s Dietitian Vol. 26 No. 9 P. 14 What’s changed for weight-inclusive and weight management dietitians?